3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
6
Nivolumab
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Sirolimus
3
Radiotherapy
3
Methods
3
Gemcitabine
3
Early Intervention, Educational
3
Drug Therapy
3
Biopsy
3
spartalizumab
2
epacadostat
2
atezolizumab
2
X-Rays
2
Topotecan
2
Surveys and Questionnaires
2
Specimen Handling
2
Palliative Care
2
Nuclear Medicine Department, Hospital
2
Ipilimumab
2
Interleukin-2
2
Educational Status
2
Dasatinib
2
Cyclophosphamide
2
Carboplatin
2
vocimagene amiretrorepvec
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Referral and Consultation
×
Gastrointestinal
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts